Biopharma Layoff Tracker 2024

Biopharma Layoff Tracker 2024. Financial and regulatory headwinds, like the march collapse of silicon valley bank and a more strident federal trade commission, further weighed on the sector. While this is not a new trend, the current trajectory is concerning, as it portends.


Biopharma Layoff Tracker 2024

Last year, we tallied 187 total layoffs among biotech companies, a 57% jump compared to 119 in 2022. View site on a desktop to sort, filter, search.

Layoff Events (Startups &Amp; S….


Layoff Events (Startups &Amp; S…., 2024


Last year, we tallied 187 total layoffs among biotech companies, a 57% jump compared to 119 in 2022.

Last Year Brought A Stock Market Slide And Layoffs For More Than 150 Drug Companies.


Last Year Brought A Stock Market Slide And Layoffs For More Than 150 Drug Companies., 2024


But here we are, launching the third annual iteration tracking industry layoffs.

Travere Tied The Layoffs To The Approval Process And Launch Of Filspari (Sparsentan), Which Has Accelerated Approval For Iga Nephropathy And Which The Company Has Been Testing For Focal Segmental Glomerulosclerosis (Fsgs).


Travere Tied The Layoffs To The Approval Process And Launch Of Filspari (Sparsentan), Which Has Accelerated Approval For Iga Nephropathy And Which The Company Has Been Testing For Focal Segmental Glomerulosclerosis (Fsgs)., 2024


Images References


Images References, 2024

As Always, If You Know Of A Layoff Occurring At.


As Always, If You Know Of A Layoff Occurring At., 2024


2023 biopharma layoffs now match 2022's total.

In The First Quarter Of 2023, 56 Biopharmas Laid Off Staff—An 87% Jump Compared To 2022, When 30 Companies Reported Layoffs For The Same Period, According To A Fierce Biotech Analysis.


In The First Quarter Of 2023, 56 Biopharmas Laid Off Staff—An 87% Jump Compared To 2022, When 30 Companies Reported Layoffs For The Same Period, According To A Fierce Biotech Analysis., 2024


And 2024 is off to a rough.

The Biotech Is Laying Off About 29% Of Its Employees And Will Focus Its Resources On The Company’s Hypoimmune Platform.


The Biotech Is Laying Off About 29% Of Its Employees And Will Focus Its Resources On The Company’s Hypoimmune Platform., 2024